U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436169) titled '2D:4D Finger Ratio and Breast Cancer in Women' on Feb. 21.
Brief Summary: This prospective study aims to evaluate the 2D:4D finger ratio in women diagnosed with breast cancer compared to healthy controls and to examine its potential association with tumor markers, including carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA 15-3).
A total of 132 women are included in the study, comprising 79 patients with breast cancer and 53 healthy controls. Participants are recruited from a breast clinic setting. Finger lengths are measured to calculate 2D:4D ratios, and serum CEA and CA 15-3 levels are recorded. Statistical analyses are...